Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-677-4 | CAS number: 68-11-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 004
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Mercaptoacetic acid
- EC Number:
- 200-677-4
- EC Name:
- Mercaptoacetic acid
- Cas Number:
- 68-11-1
- Molecular formula:
- C2H4O2S
- IUPAC Name:
- 2-sulfanylacetic acid
- Details on test material:
- Test compound: Thioglycolic acid
CAS no.: 68-11-1
Source: Bruno Bock Chemische Fabrik GmbH & Co KG
Batch: 9162
Purity: > 99%
Storage: Room temperature / darkness
Stability: Certified for the duration of this study
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Test animals:
- Species: Rat Strain: Wistar
- Age: ca. 2 months old
- Weight at dosing: ca. 200 g
- Source: Harlan-Winkelmann GmbH, Borchen (Germany)
- Acclimation period: at least 5 days
- Diet: Kliba 3883, ad libitum
- Water: Tap water, ad libitum
- Housing: Animals were housed singly in Makrolon type IIIH cages
Environmental conditions:
- Temperature: 22 +/- 2°C
- Humidity: 40-60%
- Air changes: ca. 10 air changes/h
- Photoperiod: 12h/12h
Administration / exposure
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- nose only
- Vehicle:
- other: unchanged (no vehicle)
- Details on inhalation exposure:
- Aerosol Generation and Exposure Technique:
- Mode of exposure: Animals were exposed to the aerosolized test substance in Plexiglas exposure tubes applying a directed-flow nose-only exposure principle.
- Aerosol generation: Under dynamic conditions the aqueous solution of the test article was nebulized into a baffle (pre-separator) from which the substance was conveyed into the intake of the cylindrical inhalation chamber. The test article was nebulized using a binary nozzle with conditioned compressed air. The solution was fed into the nozzle by a calibrated, digitally controlled piston, equipped with a glass syringe. Inhalation Chamber: The stainless steel directed-flow nose-only inhalation chamber has the following dimensions: diameter = 30 cm (two-chamber system), height = 28 cm (internal volume = about 7 L).
- Inhalation chamber steady-state concentration: The test atmosphere generation conditions provide an adequate number of air exchanges per hour (ca. 129 x, continuous generation of test atmosphere). Under such test conditions steady state is attained within the first two minutes of exposure (t99% = 4.6 x chamber volume/flow rate; McFarland, 1976). The ratio between the air supplied and exhausted was chosen so that approximately 80-90% of the supplied air is removed via the exhaust system. The remainder provides adequate dead-space ventilation for the exposure tubes. At each exposure port a minimal air flow rate of 0.75 l/min was provided. The test atmosphere can by no means be diluted by bias-air-flows. The inhalation chamber was operated in a well ventilated chemical fume hood.
- Air flows: During the exposure period air flows were monitored continuously and, if necessary, readjusted to the conditions required.
Inhalation Chamber Temperature and Humidity:
Temperature and humidity measurements were made using a computerized system. The values were recorded at intervals of 5 min.
Analysis of the Test Atmosphere:
- Nominal concentration: The nominal concentration was calculated from the ratio of the total quantity of test substance discharged during the exposure period and the total throughput of air through the inhalation chamber.
- Gravimetric evaluation: The test-substance concentration was determined by gravimetric analysis. Filters were weighed immediately after cessation of sampling.
- Analytical evaluation: Several samples were taken by bubbling the inhalation chamber atmosphere through gas bubblers containing an aqueous solution (0.04%) of phosphoric acid. The analytes were determined by High-Performance Chromatography (HPLC).
Characterization of Aerodynamic Particle-Size Distribution:
The samples for the analysis of the particle-size distribution were also taken in the vicinity of the breathing zone. During each exposure two samples were taken. The particle-size distribution was analyzed using a BERNER-TYPE AERAS low-pressure critical orifice cascade impactor (Hauke, Gmunden, Austria). - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- 0, 284.1, 837.2, 1441 and 3629 mg/m3
- No. of animals per sex per dose:
- 5
- Control animals:
- yes
- Details on study design:
- Body Weights:
Body weights were measured before exposure, on days 3 and 7, and weekly thereafter.
Clinical Signs:
The appearance and behaviour of each rat were examined carefully several times on the day of exposure and at least once daily thereafter.
Rectal Temperatures:
The rectal temperatures were measured shortly after cessation of exposure (approximately within ½ hour after the end of exposure) using a digital thermometer with a rectal probe for rats.
Necropsy:
All surviving rats were sacrificed at the end of the observation period and were subject to a gross-pathological examination. - Statistics:
- Necropsy findings: pair-wise Fisher test after the R x C chi-squared test. The Fisher test was only performed if differences occurred between groups in the R x C chi-squared test or if a frequency value of < 5 was calculated. Body weights: one-way ANOVA (vide infra). Physiological data: ANOVA procedure (vide infra). Initial LC50 calculation by the author used moving average Interpolation according to Scharper et al. (1994). LC50 was recalculated using a probit standard model.
Results and discussion
Effect levelsopen allclose all
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- 1 388 mg/m³ air (analytical)
- Based on:
- test mat.
- 95% CL:
- 1 000 - 2 080
- Exp. duration:
- 4 h
- Remarks on result:
- other: calculated with probit standard model
- Sex:
- male
- Dose descriptor:
- LC50
- Effect level:
- 1 981 mg/m³ air (analytical)
- Based on:
- test mat.
- 95% CL:
- 921 - 11 700
- Exp. duration:
- 4 h
- Remarks on result:
- other: calculated with probit standard model
- Sex:
- female
- Dose descriptor:
- LC50
- Effect level:
- 1 094 mg/m³ air (analytical)
- Based on:
- test mat.
- 95% CL:
- 98 - 2 130
- Exp. duration:
- 4 h
- Remarks on result:
- other: calculated with probit standard model
- Mortality:
- Mortality occurred at exposure concentrations equal to and exceeding 1441 mg/m³. In the range of the LC50-concentration, female rats appeared to be more susceptible when compared to male rats. Mortality occurred up to the first postexposure day.
- Clinical signs:
- other: Group 1: All rats tolerated the exposure without specific signs. Group 2/males: Nose: reddened. Group 3/males: bradypnea, labored breathing patterns, irregular breathing patterns, nose: reddened, nose: red encrustations, nostrils: red encrustations, pilo
- Body weight:
- Comparisons between the control and exposure group revealed transient changes in body weights at 837.2 and 1441 mg/m3 (see attached figure).
- Gross pathology:
- Animals succumbed during the observation period: Nose: red; lung: less collapsed; dark-red marbled stomach: bloated, red mucosa; intestines: bloated, reddish-mucous content, mucosa reddened; liver: light coloured; spleen: light coloured; kidneys: bilaterally light coloured; incisors: white discolouration; oral cavity: filled with bedding material; oesophagus: filled with bedding material. Animals sacrificed at the end of the observation period: The macroscopic findings in the exposure groups showed a low incidence of discolourated lungs.
- Other findings:
- Reflex measurements
A battery of reflex measurements was made on the first post-exposure day. In comparison to the rats of the control group, male rats of group 4 and some female rats in groups 2-3 exhibited changes in the reflex behavior suggestive impaired reflexes in the first post-exposure day.
Rectal temperature
Mean values are shown in Table 2. Statistical comparisons between the control and the exposure groups 3-5 revealed significantly decreased the body temperatures shortly after cessation of exposure.
Any other information on results incl. tables
Table 1: Generation and characterization of chamber atmosphere (aerosolization of the neat test article) - Mean values
Group 1 |
Group 2 |
Group 3 |
Group 4 |
Group 5 |
|
Target Conc. (mg/m³) |
Control (air) |
250 |
1200 |
1500 |
5000 |
Nominal concentration (mg/m³)a |
0 |
1408 |
5632 |
11440 |
35200 |
Gravimetric Conc. (mg/m³) |
-- |
196.6 |
837.4 |
1542 |
3865 |
Analytical concentration (mg/m³) |
-- |
284.1 |
837.2 |
1441 |
3629 |
Gravimetric:analytical (%) |
-- |
69 |
100 |
»100 |
»100 |
Recovery (%) |
-- |
20 |
15 |
13 |
10 |
Test article supply (ml/min) |
-- |
16 |
64 |
130 |
400 |
Inlet Air Flow (l/min) |
15 |
15 |
15 |
15 |
15 |
Exhaust Air Flow (l/min) |
13 |
13 |
13 |
13 |
13 |
Temperature (mean,oC) |
21.8 |
22.7 |
22.6 |
22.6 |
22.6 |
Rel. Humidity (mean, %) |
< 6.5 |
< 5.4 |
< 5 |
< 5.2 |
< 5.3 |
MMAD (µm) |
-- |
2.48 |
2.85 |
2.77 |
3.07 |
Aerosol Mass < 3 µm (%) |
-- |
59.8 |
53 |
54.6 |
49 |
Mass recovered (mg/m³) |
-- |
136.7 |
799.2 |
1310 |
3926 |
MMAD = Mass Median Aerodynamic Diameter, GSD = Geometric Standard Deviation; -- = not applicable. Recovery: Analytical concentration relative to nominal concentration. a) For calculation a specific density D204= 1.32 g/cm³ was used.
Table 2: Summary of acute inhalation toxicity - 4 hour exposure to aerosolized test substance
N |
Actual Concentration (mg/m³) |
Toxicological Result |
Onset and Duration of Signs |
Onset of Mortality |
Rectal Temperature (°C) |
1 / m |
0 |
0 / 0 / 5 |
-- |
-- |
37.6 |
2 / m |
284.1 |
0 / 5 / 5 |
0d (5h) |
-- |
37.3 |
3 / m |
837.2 |
0 / 5 / 5 |
0d – 2d |
-- |
35.3 |
4 / m |
1440.9 |
1 / 5 / 5 |
0d–4d,7d–14d |
1d |
31.1* |
5 / m |
3628.8 |
5 / 4 / 5 |
0d |
0d, 1d |
28.7** |
1 / f |
0 |
0 / 0 / 5 |
-- |
-- |
38.4 |
2 / f |
284.1 |
0 / 5 / 5 |
0d (5h) – 3d |
-- |
37.5 |
3 / f |
837.2 |
0 / 5 / 5 |
0d – 12d |
-- |
36.9* |
4 / f |
1440.9 |
5 / 5 / 5 |
0d |
1d |
35.2** |
5 / f |
3628.8 |
5 / 5 / 5 |
0d |
1d |
28.8** |
N = group assignment, m = males, f = females, * = p < 0.05, ** = p < 0.01
Values given in the 'Toxicological results' column are:
1st = number of dead animals.
2nd = number of animals with signs after cessation of exposure.
3rd = number of animals exposed.
Applicant's summary and conclusion
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- Based on the calculations obtained by the Moving Average Interpolation procedure, the approximate combined LC50 for males and females is 1388 mg/m³.
- Executive summary:
A study on the acute inhalation toxicity of THIOGLYCOLIC ACID on rats has been conducted in accordance with OECD Guideline No. 403, EU Directive 92/69/EEC, OPPTS 870.1300 and Japan MAFF, Notification No. 12 Nousan-8147. Four groups of rats were nose-only exposed to a mean aerosol concentrations of 284, 837, 1441, and 3629 mg/m³ air. The liquid aerosol generated (aerosolization of the undiluted test article) was respirable to rats and all
concentration data represent actual concentrations of the test substance in the rats breathing zone.Internationally recognized recommendations such as of SOT (1992) were fulfilled, in regard to the respirability of the aerosol generated, i.e. the MMAD was <4 µm (MMAD 2.5-3.1 µm, GSD»2.1).
Mortality occurred at exposure concentrations equal to and exceeding 1441 mg/m³. In the range of the LC50-concentration, female rats appeared to be more susceptible when compared to male rats. Based on the calculations obtained by the probit standard modele, the approximate LC50for males and females is 1891 and 1094 mg/m³, respectively, and the combined LC50 is 1388 mg/m3 . Mortality occurred up to the first postexposure day. The clinical signs observed included the following findings: bradypnea, labored breathing patterns, irregular breathing patterns, tachypnea, nasal discharge (serous), nose: reddened, nose: gray discolorations, nose: red encrustations, muzzle: red encrustations, nostrils: red encrustations, stridor, piloerection, hair-coat ungroomed, cyanosis, emaciation, motility reduced, limp, apathy, tremor (hind limbs), paralysis (all legs), high-legged gait, flaccidity (all limbs) , posture squatted, prostration, corneal opacity, tremor (entire body), reduced reflexes, decreased body weights, and hypothermia. The duration of clinical signs was governed by respiratory distress and behavioral abnormalities. At the end of the postexposure period most rats appeared to be clinically normal. Necropsy findings were suggestive that lung damage was causally related to mortality. .
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.